Literature DB >> 10837100

Drug-induced delirium.

T M Brown1.   

Abstract

Drug-induced delirium (DID) is a common and debilitating clinical problem. Identifying and treating the causes of DID is becoming easier as knowledge of the pharmacodynamic and pharmacokinetic fates of drugs increases. This article reviews basic pharmacological mechanisms and risks of DID, and ways to manage these risks.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10837100     DOI： 10.153/SCNP00500113

Source DB:  PubMed          Journal:  Semin Clin Neuropsychiatry        ISSN： 1084-3612


  7 in total

Review 1.  An approach to drug induced delirium in the elderly.

Authors:  K Alagiakrishnan; C A Wiens
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

Review 2.  [Delirium--management in the hospital: diagnosis and treatment].

Authors:  A Rahn
Journal:  Z Gerontol Geriatr       Date:  2008-10-30       Impact factor: 1.281

3.  Levofloxacin-induced delirium.

Authors:  Gleb Slobodin; Nizar Elias; Natalia Zaygraikin; Muhammad Sheikh-Ahmad; Sergiu Sabetay; Boaz Weller; Majed Odeh
Journal:  Neurol Sci       Date:  2009-02-03       Impact factor: 3.307

4.  Treating Psychotic Symptoms in Elderly Patients.

Authors:  Steven D. Targum
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-08

Review 5.  The perioperative management of pain from intracranial surgery.

Authors:  Allan Gottschalk; Myron Yaster
Journal:  Neurocrit Care       Date:  2008-10-01       Impact factor: 3.210

6.  Acute Delirium Associated With Levofloxacin.

Authors:  Yana Kogan; Nizar Elias; Alona Paz; Majed Odeh
Journal:  J Clin Med Res       Date:  2018-07-31

7.  Incidence of Drug-Induced Delirium During Treatment With Antidepressants or Antipsychotics: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2016.

Authors:  M E Friedrich; R Grohmann; U Rabl; D Winkler; A Konstantinidis; R Engel; J Seifert; S Toto; S Stübner; R Frey; S Kasper
Journal:  Int J Neuropsychopharmacol       Date:  2022-08-04       Impact factor: 5.678
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.